Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
4
×
life sciences
4
×
national
national blog main
national top stories
new york blog main
new york top stories
purdue pharma
4
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
hepatitis b
indiana blog main
indiana top stories
merck
abbvie
astrazeneca
bristol-myers squibb
clinical trials
diagnostics
gene editing
glaxosmithkline
ifm therapeutics
What
bio
roundup
drug
pricing
abbvie’s
acquisitions
advanced
advantages
arrival
award
bar
barbecuing
biggest
brings
build
buy
camping
cancer
cardiologist
center
ceo
check
cholesterol
company’s
conference
daniel
data
day
death
debut
decades
dems
dyne’s
expect
flop
gamble
gilead
given
hit
immunotherapy
Language
unset
Current search:
amgen
×
" purdue pharma "
×
" life sciences "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More